Author

Caterina Ricardi

Observed names: RICARDI, CATERINA, Ricardi, Caterina

Institution: University of Pisa

Observed institution: University of Pisa

OpenAlex ID: A5024765124

Beta-Caryophyllene, a Cannabinoid Receptor Type 2 Selective Agonist, in Emotional and Cognitive Disorders

2024 · Caterina Ricardi, Serena Barachini, et al. · International Journal of Molecular Sciences · 51

PDF

T1AM/TAAR1 System Reduces Inflammatory Response and β-Amyloid Toxicity in Human Microglial HMC3 Cell Line

2023 · Beatrice Polini, Caterina Ricardi, et al. · International Journal of Molecular Sciences · 37

PDF

Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands

2022 · Francesca Gado, Rebecca Ferrisi, et al. · Journal of Medicinal Chemistry · 35

Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB2R)

2022 · Rebecca Ferrisi, Francesca Gado, et al. · Frontiers in Chemistry · 18

The Interplay between Cannabinoid Receptors and Microglia in the Pathophysiology of Alzheimer’s Disease

2023 · Rebecca Ferrisi, Francesca Gado, et al. · Journal of Clinical Medicine · 16

PDF

Multi-Target Protective Effects of β-Caryophyllene (BCP) at the Intersection of Neuroinflammation and Neurodegeneration

2025 · Caterina Ricardi, Anna Mazzierli, et al. · International Journal of Molecular Sciences · 14

PDF

New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2

2023 · Rebecca Ferrisi, Beatrice Polini, et al. · International Journal of Molecular Sciences · 12

A Proteomic Approach Identified TFEB as a Key Player in the Protective Action of Novel CB2R Bitopic Ligand FD22a against the Deleterious Effects Induced by β-Amyloid in Glial Cells

2024 · Beatrice Polini, Lorenzo Zallocco, et al. · Cells · 10

PDF

Novel Thyroid Hormone Receptor-β Agonist TG68 Exerts Anti-Inflammatory, Lipid-Lowering and Anxiolytic Effects in a High-Fat Diet (HFD) Mouse Model of Obesity

2025 · Beatrice Polini, Caterina Ricardi, et al. · Cells · 5

PDF

Performance in Behavioral Testing in an Animal Model of Post-Surgical Hypoparathyroidism

2024 · Cristina Dettori, Francesca Ronca, et al. · Journal of Personalized Medicine · 1

PDF

Thyroid hormone metabolite 3-iodothyronamine (T1AM) as an effective repressor of microglia-mediated neuroinflammation

2023 · Beatrice Polini, Caterina Ricardi, et al. · Endocrine Abstracts · 1

Synthetic analogs of 3-iodothyronamine (T1AM) prevent [beta]-amyloid neurotoxicity in an in vitro model of alzheimer's disease (AD)

2022 · Beatrice Polini, Caterina Ricardi, et al. · Endocrine Abstracts · 1

Novel Tr-[beta] selective agonist TG68 promotes anti-inflammatory, lipid-lowering and anxiolytic effects

2024 · Beatrice Polini, Caterina Ricardi, et al. · Endocrine Abstracts

Evaluation of Irisin levels in a group of young patients with Cerebral Palsy compared with healthy matched controls

2024 · Federica Saponaro, Giuseppina Sgandurra, et al. · Endocrine Abstracts

Irisin levels are correlated with age and behavioural performance in Post-surgical HypoPT condition

2024 · Federica Saponaro, Grazia Chiellini, et al. · Endocrine Abstracts

Novel Thyroid Hormone Receptor-[beta] Agonist TG68: a polypharmacological approach for the treatment of obesity-associated diseases

2023 · Caterina Ricardi, Beatrice Polini, et al. · Endocrine Abstracts

Brain effects of combined levothyroxine (T4) and 3-iodothyronamine (T1AM) replacement therapy in a murine model of hypothyroidism

2022 · Andrea Bertolini, Caterina Ricardi, et al. · Endocrine Abstracts

3-Iodothyroacetic acid release in a mouse model of ischemia-induced synaptic dysfunction

2022 · Caterina Ricardi, Andrea Bertolini, et al. · Endocrine Abstracts

Works count: 20

Citation count: 201

H-index: 8

I10-index: 8